Increased risks of upper tract urothelial carcinoma in male and female Chinese herbalists

Journal of the Formosan Medical Association

Volumn 110, Issue 3, 2011, Pages 161-168

  Yang, Hsiao Yu ^a,b,c   Wang, Jung Der ^a,d,f   Lo, Tsai Chang ^e   Chen, Pau Chung ^a,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^c TZU CHI UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^e Public Health Bureau   (Taiwan)

^f NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Aristolochic acid; Chinese herbal drugs; Chinese herbalist; Urological cancer; Urothelial carcinoma

Indexed keywords

ADULT; ARTICLE; BLADDER CANCER; CANCER REGISTRY; CHINESE; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; FEMALE; HERBAL MEDICINE; HUMAN; INCIDENCE; KIDNEY CANCER; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; RETROSPECTIVE STUDY; RISK ASSESSMENT; TRANSITIONAL CELL CARCINOMA; URINARY TRACT; URINARY TRACT CANCER;

EID: 79955612144     PISSN: None     EISSN: 09296646     Source Type: Journal    
DOI: 10.1016/S0929-6646(11)60026-0     Document Type: Article

References (44)

1. Tyler VE. Herbal medicine: from the past to the future. Public Health Nutr 2000;3:447-52.
2. Chen FP, Chen TJ, Kung YY, et al. Use frequency of traditional Chinese medicine in Taiwan. BMC Health Serv Res 2007;7:26.
3. Hong CD. Complementary and alternative medicine in Korea: current status and future prospects. J Altern Complement Med 2001;7(Suppl 1):S33-40.
4. Yamashita H, Tsukayama H, Sugishita C. Popularity of complementary and alternative medicine in Japan: a telephone survey. Complement Ther Med 2002;10:84-93.
5. Chung V, Wong E, Woo J, et al. Use of traditional Chinese medicine in the Hong Kong special administrative region of China. J Altern Complement Med 2007;13:361-7.
6. Lee CH, Chen JJ, Liang WM. Attitudes and intentions of patients toward integrated Chinese and Western medicine in Taiwan. J Altern Complement Med 2006;12:233-6.
7. Liu CT. Health care systems in transition. II. Taiwan, Part I. A general overview of the health care system in Taiwan. J Public Health Med 1998;20:5-10.
8. Chi C, Lee JL, Lai JS, et al. The practice of Chinese medicine in Taiwan. Soc Sci Med 1996;43:1329-48.
9. Nortier JL, Martinez MC, Schmeiser HH, et al. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 2000;342:1686-92.
10. Zhang C, Wang X, Shang M, et al. Simultaneous determination of five aristolochic acids and two aristololactams in Aristolochia plants by high-performance liquid chromatography. Biomed Chromatogr 2006;20:309-18.
11. Wu KM, Farrelly JG, Upton R, et al. Complexities of the herbal nomenclature system in traditional Chinese medicine (TCM): lessons learned from the misuse of Aristolochiarelated species and the importance of the pharmaceutical name during botanical drug product development. Phytomedicine 2007;14:273-9.
12. Jong TT, Lee MR, Hsiao SS, et al. Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography/atmospheric pressure chemical ionization/tandem mass spectrometry. J Pharm Biomed Anal 2003;33:831-7.
13. Drew AK, Whyte IM, Bensoussan A, et al. Chinese herbal medicine toxicology database: monograph on Herba Asari, "xi xin". J Toxicol Clin Toxicol 2002;40:169-72.
14. Lai MN, Wang SM, Chen PC, et al. Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J Natl Cancer Inst 2009;102:1-8.
15. Yang CS, Lin CH, Chang SH, et al. Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis 2000;35:313-8.
16. Chang CH, Wang YM, Yang AH, et al. Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. Am J Nephrol 2001;21:441-8.
17. Li XB, Xing NZ, Wang Y, et al. Transitional cell carcinoma in renal transplant recipients: a single center experience. Int J Urol 2008;15:53-7.
18. Yang HY, Wang JD, Lo TC, et al. Increased mortality risk for cancers of the kidney and other urinary organs among Chinese herbalists. J Epidemiol 2009;19:17-23.
19. Chang HC, Tsai KH. Characteristics of Chinese herbalists in Taiwan. Disquisitions on the Past and Present 2004;11: 96-114. [In Chinese].
20. Chu PC, Wang JD, Hwang JS, et al. Estimation of life expectancy and the expected years of life lost in patients with major cancers: extrapolation of survival curves under high-censored rates. Value Health 2008;11:1102-9.
21. Department of Health of the Executive Branch of the Central Government. Taiwan Cancer Registry. Available at: http://crs.cph.ntu.edu.tw/main.php?Page=N1 [Date accessed: September 4, 2009].
22. National Institute for Occupational Safety and Health. Life Table Analysis System. Available at: http://www.cdc.gov/niosh/LTAS/default.html [Date accessed: September 4, 2009].
23. Cosyns JP, Jadoul M, Squifflet JP, et al. Urothelial lesions in Chinese-herb nephropathy. Am J Kidney Dis 1999;33:1011-7.
24. Lemy A, Wissing KM, Rorive S, et al. Late onset of bladder urothelial carcinoma after kidney transplantation for endstage aristolochic acid nephropathy: a case series with 15-year follow-up. Am J Kidney Dis 2008;51:471-7.
25. Zeegers MP, Tan FE, Dorant E, et al. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 2000;89:630-9.
26. Lo TC. A Case-Control Study of Chronic Renal Disease on Herbalists in Taiwan. Taipei: Taiwan University, 2003. [Dissertation].
27. Liang WM, Kuo HW, Wang CB. Prevalence of tobacco smoking, drinking and betel nut chewing among Taiwanese workers in 1999. Mid-Taiwan J Med 2002;7:146-54.
28. Gago-Dominguez M, Yuan JM, Castelao JE, et al. Regular use of analgesics is a risk factor for renal cell carcinoma. Br J Cancer 1999;81:542-8.
29. Lai MN, Lai JN, Chen PC, et al. Increased risks of chronic kidney disease associated with prescribed Chinese herbal products suspected to contain aristolochic acid. Nephrology (Carlton) 2008;14:227-34.
30. Chiou HY, Chiou ST, Hsu YH, et al. Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up study of 8,102 residents in an arseniasis-endemic area in northeastern Taiwan. Am J Epidemiol 2001;153:411-8.
31. Chen CJ, Hsu LI, Wang CH, et al. Biomarkers of exposure, effect, and susceptibility of arsenic-induced health hazards in Taiwan. Toxicol Appl Pharmacol 2005;206:198-206.
32. Department of Health of the Executive Branch of the Central Government. Annual Report of Taiwan Cancer Registry in 2004. Available at: crs.cph.ntu.edu.tw/main.php?Page=A5 [Date accessed: September 4, 2009].
33. Chan K. Progress in traditional Chinese medicine. Trends Pharmacol Sci 1995;16:182-7.
34. Cheng JT. Review: drug therapy in Chinese traditional medicine. J Clin Pharmacol 2000;40:445-50.
35. Unschuld PU. Huang Di Nei Jing Su Wen. Nature, Knowledge and Imagery in an Ancient Chinese Medical Text. London: University of California Press, 2003.
36. Hsieh SC, Lin IH, Tseng WL, et al. Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003. Chin Med 2008;23:13. DOI: 10.1186/1749-8546-3-13.
37. Arlt VM, Ferluga D, Stiborova M, et al. Is aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer? Int J Cancer 2002;101:500-2.
38. Hranjec T, Kovac A, Kos J, et al. Endemic nephropathy: the case for chronic poisoning by Aristolochia. Croat Med J 2005;46:116-25.
39. Grollman AP, Jelaković B. Role of environmental toxins in endemic (Balkan) nephropathy. J Am Soc Nephrol 2007; 18:2817-23.
40. Koh HL, Woo SO. Chinese proprietary medicine in Singapore: regulatory control of toxic heavy metals and undeclared drugs. Drug Saf 2000;23:351-62.
41. Wu TN, Yang KC, Wang CM, et al. Lead poisoning caused by contaminated Cordyceps, a Chinese herbal medicine: two case reports. Sci Total Environ 1996;182:193-5.
42. Au AM, Ko R, Boo FO, et al. Screening methods for drugs and heavy metals in Chinese patent medicines. Bull Environ Contam Toxicol 2000;65:112-9.
43. Ernst E, Thompson Coon J. Heavy metals in traditional Chinese medicines: a systematic review. Clin Pharmacol Ther 2001;70:497-504.
44. Cheung TP, Xue C, Leung K, et al. Aristolochic acids detected in some raw Chinese medicinal herbs and manufactured herbal products-a consequence of inappropriate nomenclature and imprecise labeling? Clin Toxicol 2006;44:371-8.